{"title":"将胰岛素转化为c肽或c肽指数以及将c肽转化为HOMA2-IR:单中心回顾性观察研究","authors":"Yuichiro Iwamoto, Tomohiko Kimura, Toshitomo Sugisaki, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto","doi":"10.1016/j.cca.2025.120585","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In this study, we employed machine learning to develop a conversion method for comparing immunoreactive insulin (IRI) and C-peptide immunoreactivity (CPR), which are indicators of endogenous insulin secretion capacity, using a standardized approach.</div></div><div><h3>Methods</h3><div>This is a single-center retrospective observational study of 449 patients with type 2 diabetes (T2D) who were hospitalized at our hospital and 63 patients with T2D who were treated as outpatients, focusing on patients in whom IRI and CPR were measured simultaneously.</div></div><div><h3>Results</h3><div>The gradient boosting decision tree (GBDT) model constructed for hospitalized patients used seven features, including IRI, and showed an accuracy of R<sup>2</sup> = 0.641 and MSE = 0.247 ng/mL after applying a nonlinear transformation to the CPR index (CPI). The correlation coefficient between actual CPI and predicted CPI was r = 0.943. The accuracy of the GBDT model, which nonlinearly transforms HOMA2-IR using seven features, including CPR, was R<sup>2</sup> = 0.615 and MSE = 0.268. The correlation coefficient between the actual HOMA2-IR and the predicted HOMA2-IR was r = 0.943. When the model was applied to outpatients, CPI and HOMA2-IR were significantly correlated with actual values (r = 0.820 and r = 0.812, respectively).</div></div><div><h3>Conclusions</h3><div>If either IRI or CPR is measured, it will be possible to evaluate endogenous insulin secretion capacity and insulin resistance using the same standards, and it is expected to be used as an auxiliary indicator in future clinical research and when integrating data from multiple institutions.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"578 ","pages":"Article 120585"},"PeriodicalIF":2.9000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assay-specific machine-learning models converting insulin to C-peptide or C-peptide index and C-peptide to HOMA2-IR: Single-center retrospective observational study\",\"authors\":\"Yuichiro Iwamoto, Tomohiko Kimura, Toshitomo Sugisaki, Kazunori Dan, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto\",\"doi\":\"10.1016/j.cca.2025.120585\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>In this study, we employed machine learning to develop a conversion method for comparing immunoreactive insulin (IRI) and C-peptide immunoreactivity (CPR), which are indicators of endogenous insulin secretion capacity, using a standardized approach.</div></div><div><h3>Methods</h3><div>This is a single-center retrospective observational study of 449 patients with type 2 diabetes (T2D) who were hospitalized at our hospital and 63 patients with T2D who were treated as outpatients, focusing on patients in whom IRI and CPR were measured simultaneously.</div></div><div><h3>Results</h3><div>The gradient boosting decision tree (GBDT) model constructed for hospitalized patients used seven features, including IRI, and showed an accuracy of R<sup>2</sup> = 0.641 and MSE = 0.247 ng/mL after applying a nonlinear transformation to the CPR index (CPI). The correlation coefficient between actual CPI and predicted CPI was r = 0.943. The accuracy of the GBDT model, which nonlinearly transforms HOMA2-IR using seven features, including CPR, was R<sup>2</sup> = 0.615 and MSE = 0.268. The correlation coefficient between the actual HOMA2-IR and the predicted HOMA2-IR was r = 0.943. When the model was applied to outpatients, CPI and HOMA2-IR were significantly correlated with actual values (r = 0.820 and r = 0.812, respectively).</div></div><div><h3>Conclusions</h3><div>If either IRI or CPR is measured, it will be possible to evaluate endogenous insulin secretion capacity and insulin resistance using the same standards, and it is expected to be used as an auxiliary indicator in future clinical research and when integrating data from multiple institutions.</div></div>\",\"PeriodicalId\":10205,\"journal\":{\"name\":\"Clinica Chimica Acta\",\"volume\":\"578 \",\"pages\":\"Article 120585\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica Chimica Acta\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0009898125004644\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898125004644","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
Assay-specific machine-learning models converting insulin to C-peptide or C-peptide index and C-peptide to HOMA2-IR: Single-center retrospective observational study
Background
In this study, we employed machine learning to develop a conversion method for comparing immunoreactive insulin (IRI) and C-peptide immunoreactivity (CPR), which are indicators of endogenous insulin secretion capacity, using a standardized approach.
Methods
This is a single-center retrospective observational study of 449 patients with type 2 diabetes (T2D) who were hospitalized at our hospital and 63 patients with T2D who were treated as outpatients, focusing on patients in whom IRI and CPR were measured simultaneously.
Results
The gradient boosting decision tree (GBDT) model constructed for hospitalized patients used seven features, including IRI, and showed an accuracy of R2 = 0.641 and MSE = 0.247 ng/mL after applying a nonlinear transformation to the CPR index (CPI). The correlation coefficient between actual CPI and predicted CPI was r = 0.943. The accuracy of the GBDT model, which nonlinearly transforms HOMA2-IR using seven features, including CPR, was R2 = 0.615 and MSE = 0.268. The correlation coefficient between the actual HOMA2-IR and the predicted HOMA2-IR was r = 0.943. When the model was applied to outpatients, CPI and HOMA2-IR were significantly correlated with actual values (r = 0.820 and r = 0.812, respectively).
Conclusions
If either IRI or CPR is measured, it will be possible to evaluate endogenous insulin secretion capacity and insulin resistance using the same standards, and it is expected to be used as an auxiliary indicator in future clinical research and when integrating data from multiple institutions.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.